- About Us
- Services & Solutions
- Technologies
- Discovery
- Reagent Materials Generation
- Monoclonal Antibody Discovery
- Bispecific & Multispecific Antibody Generation
- Lead Optimization
- In Vitro Lead Characterization
- In Vivo Lead Characterization
- Other Molecular Modalities
- IND Filing Support
- Protein Sciences
- Antibody Production
- Protein Production
- Protein Characterization
- Protein Sciences
- Mammalian
- Microbial
- mRNA
- Viral Vaccines
- WuXi XDC – Bioconjugation
- Testing
- Sustainability
- Careers
- Investors
- News & Resources
WuXi Biologics
Offering End-to-End Solutions
- About Us
About Us - Services & SolutionsAbout Us
- SustainabilityAbout Us
- CareersAbout Us
- InvestorsAbout Us
- News & ResourcesAbout Us
Scientific Poster Download
Poster modified on 17/10/2023
WuXiDAR4: A simple but powerful approach to produce homogeneous ADC products
Qing Zhou, Xudong Dai, Yun He, Jin Jin, Jun Wang, Li Yin, Jincai Li
Biologics Conjugation Development, WuXi XDC
Historically, conjugation of chemical payloads to mAbs (mainly IgG1 & IgG4) by reducing Cysteine inter-chain disulfide bonds dominated the conjugation strategy in the generation of ADCs. However this traditional mechanism was problematic as it typically resulted in significant amounts of heterogeneous products with a wide DAR distribution. Here we introduce the novel and proprietary WuXiDAR4 technology platform for producing ADCs more efficiently and with higher DAR4 population.
This scientific poster was originally presented during the 2023 World ADC Conference in London
Discuss This Poster
To discuss the data in this poster, please complete the form on the following page to connect with our experts.